Response to Campbell et al.'s comments on our study "Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study"

EClinicalMedicine. 2024 Oct 24:77:102895. doi: 10.1016/j.eclinm.2024.102895. eCollection 2024 Nov.

Authors

Alizée Bozonnat^{1

2

3}, Arnaud Serret-Larmande^{2

3}, Marie Beylot-Barry⁴, Martine Bagot^{1

2

3}, Adèle de Masson^{1

2

3}; Cutaneous Lymphomas French Study Group

Affiliations

¹ Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.
² INSERM U976, Institut de Recherche Saint-Louis, Paris, France.
³ Université Paris Cité, Paris, France.
⁴ Department of Dermatology, CHU de Bordeaux, BoRdeaux Institute of Oncology, BRIC INSERM U1312, INSERM BoRdeaux Institute of Oncology, Team 5, Université de Bordeaux, Bordeaux, France.

No abstract available